For sponsors & investors in new sites

A new site has no track record. Here is how to tell if it is a good bet.

What sponsors look for when a site is new, how to read the early signals, and how to invest in stages so the risk stays small.

Children and an adult building sand structures at the water's edge
What every site shows youThe finished structure, seen from a distance.
Children and an adult digging in and around sand mounds
What sponsors actually doGet close, dig in, and see what it is made of.

Sites like to present the finished castle. Sponsors learn to dig, because from a distance a solid structure and a pile of loose sand look the same.

The problem with judging a new site

Established sites are judged on history: enrollment, data quality, audit results. A startup site has none of that, so it is easy to be swayed by volume claims, a strong pitch, or a good location.

None of these predict performance. What does predict it is readiness: access to the right patients, an engaged investigator, trained people, working processes, and honest projections. Those can all be checked before the first patient is enrolled.

What sponsors care about

Six things to check before backing a new site

Each one can be verified without a trial history. Each comes with the question that exposes it.

01

Patients they can actually reach

Sponsors discount "we see a lot of patients." They want the specific population the protocol needs, where it comes from, and how many are already identified.

AskWhich patients fit this protocol today, and from which referral source?
02

An investigator who is hands-on

The principal investigator's time, oversight and judgment drive quality. A new site can borrow credibility from the investigator's clinical standing, if oversight is real.

AskHow many hours a week does the PI spend on research, and who covers when they are away?
03

Staff who are trained and delegated

A site with no trial history is judged on its people. Trained, documented, clearly delegated staff reduce the biggest startup risk: things done differently each time.

AskWho does what, who backs them up, and where is that written down?
04

Speed to activation

Contracts, budgets, IRB, and regulatory paperwork are where startup sites stall. Fast, organized responses signal a site that will also move fast during the study.

AskHow long did the last contract and budget turn take, and who owned it?
05

Clean data and compliance habits

Sponsors cannot wait for a track record, so they look for habits: source documentation, query response time, protocol adherence, and readiness for monitoring and audits.

AskWhat happens when a visit window is missed or a source note is incomplete?
06

Realistic, honest projections

The sites sponsors trust give conservative enrollment numbers and a plan for retention. Overpromising is the fastest way to lose a second study.

AskWhat is the enrollment estimate based on, and what is the fallback if it falls short?
Cutting through the noise

Turn every claim into something you can check

Descriptions are cheap and documents are not. The easiest way to separate real capability from polished language is to ask for evidence in place of adjectives.

What a site says
What to ask for instead
"We have a large patient base."
Counts matched to the protocol's eligibility criteria, the referral sources behind them, and how those patients were reached.
"Our team is experienced."
Training records, delegation log, and a named person for each study task, with a backup.
"We start up fast."
Dates from the last few contracts, budgets, and IRB approvals, and who handled each.
"We enroll well."
Projected vs. actual enrollment from past work, screen-fail rates, and why patients left.
"We are audit-ready."
Written procedures, a mock monitoring visit or internal review, and what was fixed afterward.
"Our investigator is deeply involved."
A record of investigator decisions and oversight, and a short call with the investigator, not just the coordinator.

A strong site answers these quickly and without discomfort. A weak one answers with more description. How a site responds to the request is itself part of the evaluation.

Reading the signals

What a good startup site looks like, and what should slow you down

Good signs
  • Named patient pathways. The site can describe where eligible patients come from, not just how many patients it sees.
  • Documented processes before the first study. Written procedures, training records and delegation are in place before a sponsor asks.
  • Investigator presence. The PI is visible in startup calls, visits and decisions.
  • Fast, organized responses. Questions about contracts, regulatory items and feasibility are answered completely and on time.
  • Conservative numbers. Projections are modest and sourced, with a stated backup plan.
  • A fit-first study list. The site pursues studies that match its patients and capabilities, not every study offered.
Slow down if you see
  • Vague access claims. Large patient volumes with no link to the protocol's population.
  • Absent or stretched investigator. Oversight depends on a few spare hours or on one person.
  • Staff with no clear roles. Everyone does everything, and nothing is written down.
  • Slow or disorganized paperwork. Repeated follow-ups for basic regulatory or budget items.
  • Big promises, no basis. Enrollment estimates that cannot be tied to real patients.
  • Taking every study. No view on fit, which usually means weak performance across all of them.
Investing with limited risk

Stage the bet instead of making it all at once

The strongest way to back a startup site is to let it earn each next step. Each stage has a clear gate, so the decision to continue rests on evidence rather than hope.

Evaluate

Review access, investigator, staff, and readiness against the protocol.

Gate: patients identified, processes documented

Pilot

Start with one study that fits the site's strengths, not the largest or most complex.

Gate: on-time activation

Prove

Watch the first enrollment, data quality and responsiveness against agreed checkpoints.

Gate: clean data, steady enrollment

Expand

Add studies as the site shows it can handle them.

Outcome: a trusted, repeat site

Sponsors who stage their investment learn faster, spend less on sites that do not work out, and build loyal partners in the ones that do.

A practical checklist

Ten questions to ask before committing

Why this site, and why now? A clear answer shows a plan. "We just opened" is not one.
Who is the investigator, and what is their real time commitment?
Which patients will this protocol enroll, and what is the evidence?
What is in place on day one? Staff, training, procedures, space, equipment, storage, and systems.
How fast can the site activate? Ask for the last three turnaround times, not an estimate.
What does the site do when something goes wrong? Missed visits, deviations, delayed queries.
How will the site keep patients in the study? Enrollment is half of the work; retention is the other half.
Can the site sustain itself between studies? Financial and staffing continuity matter to a sponsor planning a multi-year program.
Who outside the site vouches for it? Colleagues, collaborators, prior research partners.
What would the site do differently after its first study? Honest self-assessment is a strong signal.
How Springwoods helps

A clinician's view of site readiness

We bring frontline research and clinical experience to the question sponsors and investors keep asking: is this site ready, and for which studies? That includes a readiness perspective, input on whether a protocol fits a site's real patients, and a staged plan for bringing a new site on.

For sites: see how we help sites launch →

Start a conversation with Springwoods Strategy Group.

Message us on LinkedIn